Viant
Viant Appoints Dan Croteau Chief Executive Officer
Viant announced a leadership change on July 29, 2026. Viant appointed Dan Croteau, most recently CEO of Corza Medical, as chief executive officer to lead the medical device design and manufacturing services provider’s next phase of growth.
What changed
Dan Croteau was named Chief Executive Officer.
- Leader: Dan Croteau
- Role: Chief Executive Officer
- Effective: August 4, 2026
- Announcement date: July 29, 2026
Leadership background
Croteau has more than 30 years of leadership experience in the medical device industry and most recently served as CEO of Corza Medical, a surgical device manufacturer. He was previously president and CEO of Surgical Specialties Corporation and of Vention Medical, whose manufacturing services business was sold to Viant in 2017. He serves on the boards of Corza Medical, Resonetics, and UFP Technologies, will join Viant’s board, and holds an MBA from Harvard Business School.
The mandate
Viant said Croteau will spearhead its next phase of growth as a global partner to the world’s leading medical device organizations. Croteau said he looks forward to working with Viant’s associates and customers to build on the company’s strong foundation as a trusted partner. Chairman John Greisch said Croteau has a proven track record of building growth-oriented commercial organizations and is positioned to build on Viant’s momentum and deepen its customer relationships.
Why this matters for GTM teams
Executive appointments can precede changes in strategy, operating cadence, hiring, partnerships, and technology priorities. The useful signal is not the title alone: teams should watch the new leader’s stated mandate, prior playbook, organizational scope, and the initiatives announced during the first two quarters.
Source and methodology
This leadership profile is based on the company’s announcement. Roles, transition timing, and biographical details are presented as announced; SalesTools Research does not infer undisclosed succession plans.
Primary source: Viant leadership announcement.
Related Reports
Asembia Appoints David Skomo Chief Executive Officer
Asembia appointed David Skomo as CEO, succeeding co-founder Lawrence Irene, and said he will focus on strengthening the company’s commercial capabilities, technology platform, and pharmacy services.
Lassila and Tikanoja Appoints Ari-Pekka Määttänen President and CEO
Lassila and Tikanoja appointed Ari-Pekka Määttänen, CEO of Fintoil Oy, as President and CEO from May 1, 2027, succeeding Eero Hautaniemi to lead the circular economy company’s next phase of growth.
Sciensus Appoints James Tugendhat Chief Executive Officer
Sciensus has appointed James Tugendhat OBE, most recently Group CEO of HC-One, as Chief Executive Officer, taking over from interim CEO Gordon Cox.
Turn your sales ideas into reality today
Pick a plan and go live today. Change or cancel any time.
Get started